PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365A909. A total of 4 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $796,800 | -40.8% | 480,000 | -28.6% | 0.00% | -25.0% |
| Q2 2023 | $1,345,200 | +6.2% | 672,600 | +11.6% | 0.00% | -20.0% |
| Q1 2023 | $1,266,090 | +233.3% | 602,900 | +117.4% | 0.01% | +400.0% |
| Q4 2022 | $379,901 | +3.2% | 277,300 | -21.5% | 0.00% | 0.0% |
| Q3 2022 | $368,000 | -46.8% | 353,300 | -44.3% | 0.00% | 0.0% |
| Q2 2022 | $692,000 | +293.2% | 634,600 | +282.3% | 0.00% | – |
| Q1 2022 | $176,000 | +1855.6% | 166,000 | +1437.0% | 0.00% | – |
| Q4 2021 | $9,000 | -97.0% | 10,800 | -95.3% | 0.00% | – |
| Q3 2021 | $305,000 | -51.4% | 229,500 | -30.2% | 0.00% | -100.0% |
| Q2 2021 | $628,000 | +125.9% | 328,800 | +427.8% | 0.00% | – |
| Q1 2021 | $278,000 | +387.7% | 62,300 | +296.8% | 0.00% | – |
| Q4 2020 | $57,000 | -81.2% | 15,700 | -79.9% | 0.00% | -100.0% |
| Q3 2020 | $303,000 | +3.8% | 78,300 | +1.6% | 0.00% | 0.0% |
| Q2 2020 | $292,000 | – | 77,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 56,000 | $61,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 634,600 | $692,000 | 0.00% |
| SIMPLEX TRADING, LLC | 362,200 | $394,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |